Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Mint water extract boosts protective enzymes in skin cells.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Composite biomaterials can precisely control immune responses for better disease treatment.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Mogamulizumab can cause hair loss and skin rashes.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.